 |
- Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Intervention: Drug: methylphenidate HCl ERCT
Sponsor: Pfizer
Not yet recruiting - Conditions: Hepatic Encephalopathy; Minimal Brain Dysfunction
Intervention: Device: Critical flicker frequency assessment
Sponsor: University of Bari
Recruiting - Condition: Attention Deficit Hyperactivity Disorder
Intervention: Other: self understanding interview
Sponsors: University Hospital, Caen; Institut National de la Santé Et de la Recherche Médicale, France; Ecole Pratique des Hautes Etudes
Recruiting - Condition: Attention Deficit Disorder With Hyperactivity
Interventions: Behavioral: Group-based education; Behavioral: Waiting list; Other: Standard treatment
Sponsors: Norwegian University of Science and Technology; St. Olavs Hospital
Not yet recruiting - Condition: Attention Deficit-Hyperactivity
Interventions: Behavioral: Neuropsychological tests; Behavioral: Oculometric tests
Sponsor: University Hospital, Grenoble
Recruiting - Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Intervention: Drug: methylphenidate HCl ERCT
Sponsor: Pfizer
Not yet recruiting - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Dietary Supplement: L-theanine; Dietary Supplement: Caffeine; Dietary Supplement: L-theanine-Caffeine Combination; Other: Placebo
Sponsors: Texas Tech University; Texas Tech University Health Sciences Center
Not yet recruiting - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Methylphenidate Hydrochloride (HCl) Extended Release Chewable Tablet (ERCT); Drug: Placebo
Sponsor: Pfizer
Not yet recruiting - Condition: Attention Deficit Hyperactivity Disorder
Intervention: Other: no intervention. measure eye movement data
Sponsor: University of Wisconsin, Madison
Recruiting - Conditions: ADHD; Telemental Health
Intervention: Other: Collaborative care, Telemental health
Sponsors: Al Jalila Children's Specialty Hospital; Harvard Medical School; Dubai Health Authority
Recruiting - Condition: Attention Deficit Hyperactivity Disorder
Intervention: Device: rTMS
Sponsor: Hangzhou Normal University
Recruiting - Condition: Attention Deficit Disorder With Hyperactivity
Interventions: Behavioral: Tier 1 Classroom Management; Behavioral: Daily Report Card (DRC); Behavioral: Enhanced DRC (DRC-E); Drug: Stimulant
Sponsors: Florida International University; University at Buffalo
Recruiting - Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Interventions: Drug: Methylphenidate; Other: Matching Placebo
Sponsor: Assistance Publique - Hôpitaux de Paris
Not yet recruiting - Conditions: TBI (Traumatic Brain Injury); Brain Injuries; Stress; Attention Deficit; Executive Dysfunction
Interventions: Behavioral: State regulation skill training; Other: Treatment-as-usual
Sponsors: VA Office of Research and Development; VA Northern California Health Care System
Recruiting - Conditions: Oppositional Defiant Disorder; Attention Deficit Hyperactivity Disorder
Intervention: Behavioral: Comet
Sponsors: Karolinska Institutet; Stockholm County Council, Sweden
Recruiting - Condition: ADHD
Intervention: Drug: KP415 oral capsule
Sponsor: KemPharm, Inc.
Recruiting - Efficacy of Lisdexamfetamine Dimesylate for Promoting Occupational Success in Young Adults With ADHDCondition: Attention Deficit Disorder With Hyperactivity
Interventions: Drug: Lisdexamfetamine Dimesylate 40 MG; Drug: Placebo
Sponsor: Gregory Fabiano
Not yet recruiting - Condition: Microtia
Intervention:
Sponsor: Xijing Hospital
Not yet recruiting - Condition: Attention Deficit-Hyperactivity Disorder
Intervention: Other: Few-foods diet
Sponsors: Wageningen University; ADHD Research Centre
Recruiting - Condition: Adhd
Intervention: Other: Metabolomic approach
Sponsor: University Hospital, Tours
Recruiting - Condition: Adhd
Intervention: Behavioral: Mindfulness Cognitive Behavioral Therapy program
Sponsor: Centre Hospitalier Universitaire de Nīmes
Not yet recruiting - Conditions: Attention Deficit Hyperactivity Disorder; Problem Behavior
Intervention: Drug: Stimulant
Sponsor: Matthew O'Brien
Not yet recruiting - Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: Methylphenidate Oral Tablet
Sponsor: Centre Hospitalier Rouffach
Recruiting - Conditions: Attention Deficit Hyperactivity Disorder; Oppositional Defiant Disorder; Conduct Disorder
Interventions: Diagnostic Test: Clinical Assessment Visit; Other: fMRI scan
Sponsor: University of Michigan
Recruiting - Conditions: Attention-Deficit / Hyperactivity Disorder; Depression; Obesity
Interventions: Behavioral: Bright light therapy; Behavioral: Physical exercise
Sponsors: Goethe University; Heidelberg University; Radboud University; Hospital Vall d'Hebron; King's College London
Recruiting - Condition: ADHD
Interventions: Dietary Supplement: Oligopin®; Other: Placebo
Sponsor: Taipei Medical University
Recruiting - Condition: ADHD
Intervention: Device: QbTest
Sponsor: Nottinghamshire Healthcare NHS Trust
Not yet recruiting - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Other: Artificial Food Coloring; Other: Placebo
Sponsor: American University
Recruiting - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Behavioral: Psychoeducational group therapy; Behavioral: Waiting list; Other: Standard treatment
Sponsors: Norwegian University of Science and Technology; Helse Nord-Trøndelag HF
Recruiting - Conditions: Attention Deficit Hyperactivity Disorder; Autism Spectrum Disorder
Intervention: Drug: Lisdexamfetamine Dimesylate
Sponsors: JPM van Stralen Medicine Professional; Shire
Not yet recruiting - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Behavioral: Skill Training Group of the Dialectical Behavior Therapy; Other: Treatment as Usual
Sponsor: Hospital de Clinicas de Porto Alegre
Recruiting - Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Intervention: Drug: SHP465
Sponsor: Shire
Recruiting - Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Intervention: Drug: SHP465
Sponsor: Shire
Recruiting - Condition: Adult Attention Deficit Hyperactivity Disorder
Interventions: Drug: OPC-64005; Drug: Atomoxetine; Drug: Placebo
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Recruiting - Condition: Attention-deficit/Hyperactivity Disorder
Intervention:
Sponsor: National Taiwan University Hospital
Recruiting - Condition: ADHD
Interventions: Drug: Lisdexamfetamine dimesylate; Drug: Guanfacine Extended Release Oral Tablet; Drug: Placebo
Sponsors: King's College London; Shire
Not yet recruiting - Condition: Attention Deficit Disorder With Hyperactivity
Interventions: Other: Neurofeedback training; Other: Active Sham control; Other: Baseline control group
Sponsor: Hospices Civils de Lyon
Recruiting - Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Interventions: Drug: Placebo; Drug: SPD489 (Lisdexamfetamine dimesylate); Drug: SPD489
Sponsor: Shire
Recruiting - Conditions: Stroke; Relatives; Motor Disorder; Attention Deficit; Quality of Life
Intervention: Other: Mindfulness, MBSR
Sponsor: Zurich University of Applied Sciences
Not yet recruiting - Conditions: ADHD; Insomnia
Intervention: Behavioral: Sleep hygiene practices and behavioural intervention
Sponsors: The University of Hong Kong; Chinese University of Hong Kong
Recruiting - Condition: Attention Deficit Disorder With Hyperactivity
Intervention:
Sponsor: Göteborg University
Recruiting - Conditions: Autism Spectrum Disorder; Attention Deficit Hyperactivity Disorder
Interventions: Drug: Amphetamine; Behavioral: P-ESDM; Drug: Placebo Oral Tablet
Sponsors: Duke University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - Condition: Attention Deficit Hyperactivity Disorder
Intervention:
Sponsor: Aevi Genomic Medicine
Recruiting - Condition: Attention-Deficit Hyperactivity Disorder (ADHD)
Interventions: Drug: dasotraline; Drug: Placebo
Sponsor: Sunovion
Recruiting - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Other: MYmind mindfulness training; Other: Care-as-usual for children (8-16 years old) with ADHD
Sponsors: Karakter Kinder- en Jeugdpsychiatrie; Fonds Psychische Gezondheid; European Commission; UvA minds; Radboud University; University of Amsterdam
Recruiting - Condition: ADHD
Intervention: Other: Use of Noise Cancelling Headphones
Sponsors: Duke University; BOSE Corporation
Not yet recruiting - Conditions: Specific Learning Disorder (MeSH Unique ID: D000067559); Dyslexia (MeSH Unique ID: D004410); Conduct Disorder (MeSH Unique ID: D019955)
Intervention: Behavioral: Strategies Enhancing Reading in Older Underperf. Students
Sponsors: Baylor College of Medicine; University of Houston; Harris County Juvenile Probation Department (HCJPD); Connecticut Court Support Services Division (CSSD); MindTrust Labs, LLC
Not yet recruiting - Conditions: Attention Deficit Disorder With Hyperactivity; Attention-Deficit-Disordered Children
Interventions: Behavioral: Cognitive Behavorial Therapy (CBT); Behavioral: Body mediation
Sponsor: University Hospital, Montpellier
Recruiting - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Methylphenidate LA (Ritalin); Drug: Mixed Amphetamine Salts XR (Adderall)
Sponsors: Massachusetts General Hospital; Massachusetts Institute of Technology
Recruiting - Condition: ADHD
Intervention: Drug: Atomoxetine Hydrochloride
Sponsors: Children's Mercy Hospital Kansas City; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - Conditions: ADHD; Attention Deficit Hyperactivity Disorder; Neurodevelopmental Disorders
Intervention: Behavioral: OST Intervention for participants with Organizational skill difficulties
Sponsor: New York University School of Medicine
Recruiting - Condition: Attention Deficit/Hyperactivity Disorder
Interventions: Drug: Oxytocin nasal spray; Drug: Placebo nasal spray
Sponsor: Massachusetts General Hospital
Recruiting - Conditions: Depression; Anxiety; Attention Deficit Hyperactivity Disorder; Oppositional Defiant Disorder; Parent-Child Relations; Substance Use
Interventions: Other: Training in management of children's mental health problems; Other: Current collaborative care protocol
Sponsors: Johns Hopkins University; National Institute of Mental Health (NIMH)
Recruiting - Conditions: Autism Spectrum Disorder; Attention Deficit Hyperactivity Disorder
Intervention: Dietary Supplement: Vayarin
Sponsor: Institute of Mental Health, Singapore
Recruiting - Condition: Disruptive Behavior
Intervention: Other: Teaching intervention
Sponsors: Children's Hospital of Eastern Ontario; University of Manitoba; University of Calgary; Dalhousie University; Children's Hospital of Western Ontario; Northern Ontario School of Medicine; McMaster University; University of Alberta
Recruiting - Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: Melatonin 5 mg
Sponsors: Hospital Israelita Albert Einstein; Fundação de Amparo à Pesquisa do Estado de São Paulo; University of Sao Paulo
Not yet recruiting - Condition: ADHD
Interventions: Device: Active MeRT Treatment; Device: Sham MeRT Treatment
Sponsor: Newport Brain Research Laboratory
Recruiting - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Behavioral: CET: Central Executive Training; Behavioral: CET: Comparison Executive Training
Sponsors: Florida State University; National Institutes of Health (NIH); National Institute of Mental Health (NIMH)
Recruiting - Conditions: Substance Use; Conduct Disorders in Adolescence; Depression; Anxiety
Interventions: Behavioral: FCU-Online, web/ mobile only; Behavioral: FCU-Online, web/ mobile + coach
Sponsors: University of Oregon; National Institute on Drug Abuse (NIDA)
Recruiting - Conditions: ADHD; ADD
Interventions: Dietary Supplement: Calanus oil; Other: Medical Paraffin
Sponsor: University Hospital of North Norway
Recruiting - Condition: Conduct Disorder
Intervention: Behavioral: Stop, Now and Plan Youth Justice Model
Sponsors: Centre for Addiction and Mental Health; Ontario Mental Health Foundation
Recruiting - Condition: Conduct Disorder
Interventions: Other: MBT-CD; Other: treatment as usual (TAU)
Sponsors: Heidelberg University; Heidelberg University, Psychotherapy Research Department; Heidelberg University, Clinic for Child and Youth Psychiatry; KABEG Clinic Klagenfurt, Child and Youth Psychiatry; Mainz Johannes Gutenberg University, Clinic for Child and Youth Psychiatry and Psychotherapy
Recruiting - Condition: Attention-deficit/Hyperactivity Disorder
Intervention:
Sponsor: National Taiwan University Hospital
Recruiting - Condition: Attention Deficit Disorder With Hyperactivity
Interventions: Behavioral: cognitive behavior group therapy; Other: Treatment as usual
Sponsors: St. Olavs Hospital; Norwegian University of Science and Technology
Recruiting - Conditions: Autism; Attention Deficit Hyperactivity Disorder; Autism Spectrum Disorder
Interventions: Dietary Supplement: a2 milk; Dietary Supplement: a1 containing milk
Sponsors: Northumbria University; ESPA Research; a2 Milk Company Ltd.
Recruiting - Condition: Attention Deficit Hyperactivity Disorder
Intervention:
Sponsors: Duke University; National Institute of Mental Health (NIMH)
Recruiting - Conditions: Attention Deficit Hyperactivity Disorder; Alcohol-Related Disorders; Substance-Related Disorders
Interventions: Behavioral: SUCCEEDS Program; Behavioral: Living a Healthy College Lifestyle
Sponsors: University of Maryland; University of Memphis
Recruiting - Conditions: Cannabis Use Disorder; Attention-deficit/Hyperactivity Disorder
Interventions: Drug: Adderall-XR; Drug: Matched placebo
Sponsors: New York State Psychiatric Institute; National Institute on Drug Abuse (NIDA)
Recruiting - Condition: Attention Deficit Hyperactivity Disorder
Intervention:
Sponsors: Medice Arzneimittel Pütter GmbH & Co KG; University Hospital, Essen
Recruiting - Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Interventions: Drug: Methylphenidate compounds and /or Amphetamine compounds and/or Strattera or Guanfacine; Behavioral: Aerobic Exercise
Sponsor: McGill University Health Center
Recruiting - Conditions: Mood Disorder; Disruptive Behavior Disorders
Interventions: Drug: Oxytocin; Drug: Placebo
Sponsor: University of Nebraska
Recruiting - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Rhodiola; Drug: Placebo
Sponsor: Hospital de Clinicas de Porto Alegre
Recruiting - Condition: Attention Deficit/Hyperactivity Disorder
Interventions: Drug: Rhodiola; Drug: Placebo
Sponsor: Hospital de Clinicas de Porto Alegre
Recruiting - Conditions: Traumatic Brain Injury; Attention Deficit Disorder
Interventions: Drug: Lisdexamfetamine; Drug: Placebo
Sponsors: Vanderbilt University; Shire
Recruiting - Condition: ADHD
Interventions: Dietary Supplement: Pycnogenol; Drug: Methylphenidate; Other: Placebo
Sponsor: Nina Hermans
Recruiting - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Behavioral: STAND (Behavior Therapy + Motivational Interviewing); Behavioral: Usual Care
Sponsor: Florida International University
Recruiting - Conditions: Nonorganic Insomnia; Neurodevelopmental Disorders; Primary Insomnia
Intervention: Behavioral: BNBD-NDD Intervention
Sponsor: IWK Health Centre
Not yet recruiting - Condition: Attention Deficit Hyperactivity Disorder
Intervention: Device: DC-Stimulator (PLUS version)
Sponsor: Massachusetts General Hospital
Recruiting - Conditions: Attention Deficit Disorder; Attention Deficit Hyperactivity Disorder
Interventions: Drug: Lisdexamfetamine; Drug: Placebo
Sponsors: New York University School of Medicine; Shire
Recruiting - Conditions: Attention Deficit Hyperactivity Disorder; Autism Spectrum Disorders
Interventions: Other: Intervention Group; Other: Control Group
Sponsors: Duke-NUS Graduate Medical School; Institute of Mental Health, Singapore; Agency for Science, Technology and Research
Recruiting - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Behavioral: Cognitive Behavioural & Skills Training; Behavioral: Supportive Group Therapy; Other: Treatment as Usual - community resources; Drug: Methylphenidate or amphetamine product
Sponsors: McGill University Health Center; Canadian Institutes of Health Research (CIHR)
Recruiting - Conditions: Anxiety; Attention Deficit Hyperactivity Disorder (ADHD); Autistic Spectrum Disorder (ASD)
Interventions: Behavioral: Secret Agent Society (SAS) Program; Other: Waitlist Group / Treatment As Usual
Sponsor: Weill Medical College of Cornell University
Recruiting - Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Interventions: Behavioral: Cogmed; Behavioral: Presco
Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Methylphenidate HCl ER tablets 1; Drug: Placebo; Drug: Methylphenidate HCl ER tablets 2; Drug: Methylphenidate HCl ER for suspension
Sponsors: Massachusetts General Hospital; Food and Drug Administration (FDA); Center for Psychiatry And Behavioral Medicine Inc.
Recruiting - Conditions: DMDD (Disruptive Mood Dysregulation Disorder); ADHD (Attention Deficit Hyperactivity Disorder); ODD (Oppositional Defiant Disorder)
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Behavioral: Brief Early Intervention; Behavioral: Parent Training with Adolescent Cognitive Behavioral Therapy; Drug: Methylphenidate
Sponsor: Florida International University
Recruiting - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: mixed amphetamine salts-extended release (MAS-XR); Drug: Placebo
Sponsors: University of Cincinnati; National Institute of Mental Health (NIMH)
Recruiting - Conditions: Attention Deficit Hyperactivity Disorder; Substance Use Disorder
Interventions: Drug: Methylphenidate; Drug: Placebo
Sponsor: Region Västmanland
Recruiting - Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: Methylphenidate
Sponsor: Region Västmanland
Recruiting - Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Intervention: Drug: SPD489
Sponsor: Shire
Recruiting - Condition: Attention Deficit Disorder With Hyperactivity
Interventions: Drug: Methylphenidate (MPH); Drug: Atomoxetine
Sponsor: Asan Medical Center
Recruiting - Conditions: Alcoholism; Attention Deficit Disorder With Hyperactivity
Intervention: Behavioral: cognitive and psychiatric assessment
Sponsors: University Hospital, Lille; Institute for Scientific Research on Beverages (France)
Recruiting - Conditions: Attention Deficit Disorder With Hyperactivity Disease; Hyperkinesis; Attention Deficit and Disruptive Behavior Disorders
Interventions: Drug: Tipepidine Hibenzate; Drug: Placebo
Sponsor: Chiba University
Recruiting - Conditions: Cigarette Smoking; Smoking Cessation
Interventions: Behavioral: Contingency Management (CM); Drug: Transdermal nicotine skin patches (i.e. Habitrol); Other: Supportive Counseling
Sponsors: Duke University; National Institute on Drug Abuse (NIDA)
Recruiting - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Guanfacine; Drug: Lisdexamfetamine
Sponsors: New York State Psychiatric Institute; Columbia University
Recruiting - Condition: Attention-Deficit/Hyperactivity Disorder
Intervention: Device: Neurofeedback treatment
Sponsors: Ohio State University; National Institute of Mental Health (NIMH); University of North Carolina
Recruiting - Condition: Disruptive Behavior Disorders
Intervention: Behavioral: Behavioral Parent Training
Sponsors: University of North Carolina, Chapel Hill; National Institute of Mental Health (NIMH)
Recruiting - Condition: Attention Deficit Disorder With Hyperactivity
Intervention:
Sponsor: University of California, Los Angeles
Recruiting - Condition: Attention Deficit Disorder
Interventions: Behavioral: SCP training; Behavioral: Live Z-score training; Behavioral: WM training
Sponsors: Karolinska Institutet; Stockholm County Council, Sweden; Child and Adolescent Psychiatry, Stockholm; Stiftelsen Sunnerdahls Handikappfond; Swedish Foundation for Strategic Research
Recruiting - Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: Dextromethorphan
Sponsor: Tri-Service General Hospital
Available - Condition: Attention Deficit Disorder With Hyperactivity
Intervention:
Sponsor: National Human Genome Research Institute (NHGRI)
Recruiting - Conditions: Attention Deficit Hyperactivity Disorder; ADHD
Interventions: Other: fMRI scans; Drug: Atomoxetine arm; Drug: Methylphenidate arm
Sponsors: Icahn School of Medicine at Mount Sinai; National Institute of Mental Health (NIMH)
Recruiting - Conditions: Bipolar Disorder; Attention Deficit Disorder With Hyperactivity; Attention Deficit Disorder Without Hyperactivity; Generalized Anxiety Disorder; Healthy
Intervention:
Sponsors: Bradley Hospital; National Institute of Mental Health (NIMH)
Recruiting - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Lisdexamfetamine; Drug: Placebo
Sponsors: New York State Psychiatric Institute; Shire
Recruiting - Condition: Attention Deficit Hyperactivity Disorder
Intervention: Device: treatment by HLPFC coil
Sponsor: Brainsway
Recruiting - Condition: Attention Deficit and Hyperactivity Disorder
Intervention: Drug: ND0801
Sponsor: NeuroDerm Ltd.
Recruiting - Condition: Attention Deficit/Hyperactivity Disorder
Intervention: Other: Physical activity
Sponsor: Meir Medical Center
Not yet recruiting - Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Ritalin; Drug: Placebo
Sponsor: McGill University
Recruiting
Clinical Trial Locations